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The urokinase plasminogen activator receptor (uPAR) is a GPI-linked receptor in 
membrane rafts on HUVEC that shuttles between proteins, modulating their 
behavior. In order to describe the regulatory functions of uPAR, its interaction with 
high molecular weight kininogen (HK) was mapped. Using purified HK, kallikrein-
cleaved 56 kDa HK (56HKa) and 46 kDa HK (46HKa), low molecular weight 
kininogen (LK) and the isolated 56 kDa light chain of HK (LC), we mapped where 
uPAR binds to HK and where HK binds to soluble, recombinant uPAR (suPAR). The 
regions on HK that bind to uPAR were determined first. Biotin-HK binding to HUVEC 
is inhibited by HK, 56HKa or 46HKa with an IC50 of 110, 110 or 55 nM, respectively. 
Biotin-HK binding to suPAR also is inhibited by HK, 56HKa, or 46HKa with an IC50 of 
60, 100, or 9 nM, respectively. The region on the light chain of HK and 46HKa that 
binds best to suPAR is H477-G496. Biotin-HK or -46HKa also binds by its heavy 
chain to suPAR at 10-fold lower affinity. The heavy chain HK/46HKa binding region 
to suPAR is C333-K345. Biotinylated peptides of these suPAR binding regions on HK 
specifically bind to suPAR. The HK binding site(s) on uPAR was determined next. 
Mab 3139 that blocks HK binding to HUVEC and suPAR immunoblots epitopes on 
uPAR's domains 2 and 3. Purified domain 1 (D1) of uPAR blocks biotin-HK and -
46HKa binding to suPAR 18-35%. Purified isolated domains 2 & 3 (D2D3) block 
biotin-HK or -46HKa binding 55-60%. Combined D1 and D2D3 completely inhibit 
biotin-HK or -46HKa binding to suPAR. Mutagenizing the uPA binding region on the 
aminoterminal portion of domain 2 of suPAR does not interfere with HK binding. 
Fine mapping of the HK binding site on uPAR was performed by using sequential 
and overlapping 20 amino acid peptides prepared from uPAR. Two regions on uPAR 
contribute to HK binding. One region on the carboxyterminal end of D2 (L166-T195) 
blocks HK binding to HUVEC or suPAR and, when biotinylated, directly binds to HK. 
A second region on the aminoterminal portion of D3 (Q215-N255) blocks HK binding 
to HUVEC or suPAR and, when biotinylated, directly binds to HK. Both suPAR and 
recombinant cytokeratin 1 block biotin-HK or -46HKa binding to suPAR with equal 
affinity (IC50 = 1 µM). These investigations indicate that HK has the ability to 
intimately interact with uPAR. This activity influences vitronectin's interactions with 
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uPAR and uPAR's role in kallikrein formation, angiogenesis, and thrombosis 
prevention.
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